Anna Ryan Hemnes MD

Critical Care Medicine, Pulmonary Vascular Medicine

Associate Professor, Medicine, Vanderbilt University School of Medicine

Summary

Dr. Anna Hemnes is a pulmonologist in Nashville, TN and is affiliated with multiple hospitals in the area, including Vanderbilt University Medical Center and Tennessee Valley Healthcare System. She received her medical degree from Johns Hopkins University and has been in practice 18 years. She specializes in pulmonary vascular medicine and is experienced in severity of illness index and insulin resistance.

Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2006
Johns Hopkins UniversityResidency, Internal Medicine, 1999 - 2002
Johns Hopkins University School of MedicineClass of 1999

PubMed

Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients.
Franck F Rahaghi, Marc Humbert, Marius M Hoeper, R James White, Robert P Frantz
The Lancet. Respiratory Medicine. 2025-04-01
Alterations in Mitochondrial Function in Pulmonary Vascular Diseases.
Samar Farha, Kewal Asosingh, Paul M Hassoun, John Barnard, Suzy Comhair
Antioxidants & Redox Signaling. 2025-03-01
Medication Non-Adherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).
Eric W Robbins, Kaitlin Bradley, David B Badesch, Charles Burger, Amy M Chybowski
Annals of the American Thoracic Society. 2025-02-18

Clue to Salt-Sensitive Blood Pressure FoundOctober 21st, 2024
Anna Hemnes Named Director of the Division of Allergy, Pulmonary and Critical Care MedicineMarch 29th, 2024
American Society for Clinical Investigation Honors 10 Vanderbilt PhysiciansFebruary 9th, 2023
Join now to see all

Genomic and Circulating Predictors of PAH responseVANDERBILT UNIVERSITY MEDICAL CENTER2019–2028
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary HypertensionVANDERBILT UNIVERSITY MEDICAL CENTER2022–2027
Mentorship in Pulmonary Vascular DiseaseVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
Mentorship in Pulmonary Vascular DiseaseVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
Gender Differences And Endothelin Responses In Right Ventricular Afterload StressNational Heart, Lung, And Blood Institute2008–2011
PDE5 Inhibition Modulates Right Ventricular FailureNational Heart, Lung, And Blood Institute2006
PDE5 Inhibition Modulates Right Ventricular FailureNational Heart, Lung, And Blood Institute2005